XML 29 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Consolidated Statements of Operations      
Revenue $ 46.7 $ 21.8 $ 43.0
Operating expenses:      
Research and development 180.4 108.4 67.2
General and administrative 61.6 38.3 27.3
Total operating expenses 242.0 146.7 94.5
Loss from operations (195.3) (124.9) (51.5)
Other income (expense)      
Other income, net 2.5 2.1 1.4
Interest income 1.9 3.6 4.6
Interest expense (0.1) (0.1) (0.1)
Total other income 4.3 5.6 5.9
Loss from equity method investment 0.0 0.0 (24.7)
Net loss $ (191.0) $ (119.3) $ (70.3)
Net loss per common share - basic (in usd per share) $ (3.82) $ (3.02) $ (2.13)
Net loss per common share - diluted (in usd per share) $ (3.82) $ (3.02) $ (2.13)
Weighted average common shares outstanding - basic (in shares) 50.0 39.5 32.9
Weighted average common shares outstanding - diluted (in shares) 50.0 39.5 32.9
Consolidated Statements of Comprehensive Loss      
Net loss $ (191.0) $ (119.3) $ (70.3)
Other comprehensive loss:      
Unrealized (loss) gain on available-for-sale securities (5.2) 0.5 0.3
Comprehensive loss $ (196.2) $ (118.8) $ (70.0)